NEXTURNBIOSCIENCE Co., Ltd.

KOSDAQ:A089140 Stock Report

Market Cap: ₩31.3b

NEXTURNBIOSCIENCE Past Earnings Performance

Past criteria checks 0/6

NEXTURNBIOSCIENCE has been growing earnings at an average annual rate of 4.8%, while the Machinery industry saw earnings growing at 17.8% annually. Revenues have been growing at an average rate of 35.1% per year.

Key information

4.8%

Earnings growth rate

14.2%

EPS growth rate

Machinery Industry Growth18.9%
Revenue growth rate35.1%
Return on equity-16.4%
Net Margin-65.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

NEXTURNBIOSCIENCE's (KOSDAQ:089140) Attractive Earnings Are Not All Good News For Shareholders

Mar 28
NEXTURNBIOSCIENCE's (KOSDAQ:089140) Attractive Earnings Are Not All Good News For Shareholders

Recent updates

NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) 38% Share Price Plunge Could Signal Some Risk

Dec 02
NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) 38% Share Price Plunge Could Signal Some Risk

NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) Shares Climb 33% But Its Business Is Yet to Catch Up

Oct 17
NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) Shares Climb 33% But Its Business Is Yet to Catch Up

NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) 33% Price Boost Is Out Of Tune With Revenues

Oct 17
NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) 33% Price Boost Is Out Of Tune With Revenues

Does NEXTURNBIOSCIENCE (KOSDAQ:089140) Have A Healthy Balance Sheet?

Aug 13
Does NEXTURNBIOSCIENCE (KOSDAQ:089140) Have A Healthy Balance Sheet?

NEXTURNBIOSCIENCE's (KOSDAQ:089140) Attractive Earnings Are Not All Good News For Shareholders

Mar 28
NEXTURNBIOSCIENCE's (KOSDAQ:089140) Attractive Earnings Are Not All Good News For Shareholders

Shareholders Of NexturnLtd (KOSDAQ:089140) Must Be Happy With Their 119% Total Return

Jan 25
Shareholders Of NexturnLtd (KOSDAQ:089140) Must Be Happy With Their 119% Total Return

Revenue & Expenses Breakdown

How NEXTURNBIOSCIENCE makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A089140 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2435,857-23,5916,600468
30 Jun 2436,219-24,6736,705508
31 Mar 2438,0798,8688,327508
31 Dec 2341,2589,2757,972483
30 Sep 2338,68826,1248,008518
30 Jun 2336,61422,8048,507613
31 Mar 2329,716-2,1767,094761
31 Dec 2223,463-4,8797,050893
30 Sep 2218,0811,5845,4941,059
30 Jun 2213,0523,2545,730990
31 Mar 2215,140-7,7695,804963
31 Dec 2116,972-4,4335,127916
30 Sep 2116,644-9,1205,767925
30 Jun 2115,608-8,4674,535993
31 Dec 209,685-2,4363,6381,021

Quality Earnings: A089140 is currently unprofitable.

Growing Profit Margin: A089140 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A089140 is unprofitable, but has reduced losses over the past 5 years at a rate of 4.8% per year.

Accelerating Growth: Unable to compare A089140's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A089140 is unprofitable, making it difficult to compare its past year earnings growth to the Machinery industry (-1.8%).


Return on Equity

High ROE: A089140 has a negative Return on Equity (-16.39%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 16:20
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NEXTURNBIOSCIENCE Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
KYUNG SEOB KIMShinhan Investment Corp.
Sun Hwa LeeSK Securities Co., Ltd.